Octapharma AG - Company Profile
Powered by 
All the sales intelligence you need on Octapharma AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Octapharma AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Octapharma AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Octapharma AG (Octapharma) is a global healthcare company primarily engaged in the development and manufacturing of high-quality human protein products. The company focuses on three therapeutic areas: haematology, immunotherapy, and critical care. The company sources human proteins from human plasma and human cell lines, utilizing its own plasma donation centers and other external sources. Octapharma develops and manufactures medicines for patients in those therapeutic areas.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Octapharma is advancing its R&D initiatives by integrating scientific excellence, automation, and data integration to create an environment where ideas and experiments scale naturally over time. The company's Heidelberg R&D site is a hub for real-time experiments, data analysis, and robotic systems that handle repetitive tasks. The focus is on VHH antibodies, also known as Nanobodies, which are engineered for strength, stability, and pharmacokinetics. The R&D team employs next-generation sequencing and machine learning to optimize these antibodies for therapeutic use, accelerating the discovery process and improving precision. The R&D units of the company include the Heidelberg R&D site, which is responsible for conducting experiments and data analysis in real-time. The R&D Molecular Design team focuses on optimizing VHH antibodies for therapeutic applications. The company has more than 30 projects in the R&D pipeline The Product & Process Science division is involved in yield improvement projects for existing products. In FY2025, the company spent EUR117 million on its R&D activities, which as a percentage of revenue, stood at 3.2%.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer